150 Participants Needed

Prevention Ambassadors for HIV Service Engagement

HP
Overseen ByHeather Pines
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: San Diego State University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Prevention Ambassadors for HIV Service Engagement?

Research shows that training peer mentors and patient advocates can effectively increase engagement and attendance in HIV care. Programs like MAPPS, which train peer mentors, have been found feasible and effective in promoting patient self-care and adherence to HIV treatment.12345

How does the Prevention Ambassadors treatment differ from other HIV treatments?

The Prevention Ambassadors treatment is unique because it involves training individuals as peer health advocates to engage and support others in HIV prevention, focusing on social networks and interpersonal relationships rather than traditional medical interventions.678910

What is the purpose of this trial?

HIV testing and service uptake are infrequent among people who use drugs (PWUD) in the United States. In partnership with a community-based syringe service program (SSP), this project will develop the SSP-based "Prevention Ambassadors" (PA) intervention to promote HIV testing and service uptake among PWUD via the secondary distribution (i.e., peer delivery) of HIV self-testing (HIVST) kits with local HIV service information and referrals to HIV service navigation in the social networks of SSP clients (i.e., PWUD). The PA intervention will then be piloted to assess its preliminary effects, acceptability, and feasibility among PWUD in the Ending the HIV Epidemic priority jurisdiction of Riverside County, California.

Research Team

HA

Heather A Pines

Principal Investigator

San Diego State University

AR

Angela R Bazzi

Principal Investigator

University of California, San Diego

Eligibility Criteria

This trial is for people who use drugs (PWUD) in Riverside County, California, and are clients of a syringe service program (SSP). It's designed to help them get tested for HIV and connect with HIV services. The specific eligibility criteria aren't provided here, but typically participants would need to meet certain health conditions and agree to the study procedures.

Inclusion Criteria

Index Participant: Reporting drug use (past month)
Index Participant: Having other people who use drugs (PWUD) in one's social network
Peer-Recruit Participant: Reporting drug use (past 3 months)
See 2 more

Exclusion Criteria

Persons who participated in formative study activities related to the development of the PA intervention will not be eligible to participate.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

The Prevention Ambassadors intervention is piloted to promote HIV testing and service uptake among PWUD via peer delivery of HIV self-testing kits

3 months

Follow-up

Participants are monitored for PrEP/ART uptake, HIV testing, and linkage to PrEP/HIV care

3 months

Treatment Details

Interventions

  • Prevention Ambassadors
Trial Overview The 'Prevention Ambassadors' intervention is being tested. This involves PWUD distributing HIV self-testing kits within their networks alongside information about local HIV services and referrals. The goal is to see if this peer-led approach increases engagement with HIV testing and services.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: SSP Standard of CareExperimental Treatment1 Intervention
Group II: Prevention AmbassadorsExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

San Diego State University

Lead Sponsor

Trials
182
Recruited
119,000+

University of California, San Diego

Collaborator

Trials
1,215
Recruited
1,593,000+

Dap Health

Collaborator

Trials
1
Recruited
150+

University of California, Riverside

Collaborator

Trials
33
Recruited
14,400+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials
2,658
Recruited
3,409,000+

Findings from Research

Eight patient advocates received 18 hours of training in basic counselling skills over 3 months to support users of antiretroviral therapy (ART), showing promising results in several counselling activities.
While the advocates demonstrated acceptable skills in areas like summarizing and encouraging, they needed further training in more complex counselling techniques such as exploring feelings and challenging clients, highlighting areas for improvement in their support roles.
Training lay counsellors to provide psychosocial support to ART users: successes and failures.Kagee, A.[2013]
The MAPPS training program successfully trained HIV-positive peer mentors to effectively deliver a comprehensive behavioral change intervention aimed at increasing engagement in HIV care, demonstrating both feasibility and effectiveness.
Mentors rated the training program highly, and objective assessments showed they could meet the necessary standards for intervention fidelity, indicating that peer-led approaches can be a valuable strategy in promoting patient self-care in HIV treatment.
Development and pilot testing of a standardized training program for a patient-mentoring intervention to increase adherence to outpatient HIV care.Cully, JA., Mignogna, J., Stanley, MA., et al.[2021]
Improving engagement in HIV care is essential for treatment success, as it affects both individual health outcomes and public health efforts.
Key factors influencing engagement include the need for distinct strategies for initial linkage and retention in care, the identification of patients at risk through missed appointments, and the importance of ancillary services in supporting patients.
Improving engagement in HIV care: what can we do?Mugavero, MJ.[2008]

References

Training lay counsellors to provide psychosocial support to ART users: successes and failures. [2013]
Development and pilot testing of a standardized training program for a patient-mentoring intervention to increase adherence to outpatient HIV care. [2021]
Improving engagement in HIV care: what can we do? [2008]
True User Involvement by People Living With HIV is Possible: Description of a User-driven HIV Clinic in Norway. [2019]
Impact of an Enhanced Patient Care Intervention on Viral Suppression Among Patients Living With HIV in Kenya. [2023]
The Risk Avoidance Partnership: Training Active Drug Users as Peer Health Advocates. [2021]
Participation in two phase II prophylactic HIV vaccine trials in the UK. [2016]
Pre/post evaluation of a pilot prevention with positives training program for healthcare providers in North West Province, Republic of South Africa. [2020]
Leveraging social networks for identification of people living with HIV who are virally unsuppressed. [2023]
10.United Statespubmed.ncbi.nlm.nih.gov
Voices from the trenches: facilitators' perspectives on HIV risk reduction interventions. [2012]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity